ArticleCureus2024
Saddle Pulmonary Embolism Following Total Knee Arthroplasty: A Rare Incidence.
Article in Cureus, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Pulmonary embolism (PE) is a life-threatening condition that occurs due to the blockage of the pulmonary artery by blood clots. The occurrence of PE after total knee arthroplasty (TKA) is quite rare. Individuals with a history of PE have a high risk of recurrent venous thromboembolism (VTE). We have encountered a case of saddle PE (SPE) following TKA. The patient underwent a TKA due to advanced osteoarthritis. She started to develop respiratory distress after day 2 of surgery. Further investigation showed that she developed SPE. The conclusion from this case is that, while the occurrence is rare, it is critical to identify the risk factors for each patient prior to surgery. Individuals with VTE are at risk of developing recurrent VTE. Those with a previous history of VTE may require long-term anticoagulant medication to prevent a recurrence. Early diagnosis of the risk factor for VTE before the surgical procedure helps assure a positive outcome and prognosis following the procedure. As an additional benefit, it will lower the rates of perioperative morbidity and mortality.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.